Euro-PAD unites several key research cohorts with a shared focus on early Alzheimer’s detection and prevention, including: ALFA+, AMYPAD-PNHS, BioFINDER, EMIF-AD, EPAD-LCS, gMAD, INSIGHT-46, INSIGHT-preAD, Prevent-AD, PREVENT, REAL-AD, Rotterdam study, SCIENCe and T-POT.

These cohorts provide crucial data in areas, such as genetics, plasma biomarkers, proteomics, lifestyle factors, microbiome, (advanced) MR imaging sequences, amyloid- and tau-PET imaging, cognitive functioning, and digital outcomes.

Euro-PAD has established specific working groups to ensure high quality data across fields, optimal harmonization approaches, and swift implementation of novel processing algorithms to enrich the database on a regular basis. The working groups represent clinical/digital tools, imaging, genetics and omics, fluid biomarkers, and disease modeling.

Euro-PAD partners include a wide range of institutions, from academic to industry and a patient organisation from several EU countries including: Amsterdam UMC, UC Louvain, KU Leuven, Barcelonaβeta: Alzheimer's Research Center, Hôpital Pitié-Salpêtrière Paris, Université de Genève, University of Gothenburg, Life Molecular Imaging, GE HealthCare, Alzheimer Europe.